Increase production of Covaxin to 100 million doses per month by September 2021: Center


Amid the increase in COVID-19 cases in the country, various states, including Karnataka and Maharashtra, have reported a shortage of vaccines.

India is increasing stocks of COVID-19 vaccines on a war footing, Union Health Minister Harsh Vardhan has said.

Dr Harsh Vardhan said on Friday that due to the COVID-19 vaccine shortage in the country, the production of the Covaxin vaccine will increase tenfold, that is, the production of Covaxin will increase by 10 million doses per month to 100 million doses by September 2021.

ALSO READ  Tokyo area governors urge people to stay home during Golden Week vacation

“Increase the supply of COVID19 vaccines on a war footing!” Covaxin production will be increased from 1 cr doses / month currently to 10 cr by September 2021 by increasing capacity and adding more manufacturers. Grants for the same are provided by DBTIndia as part of its COVID suraksha mission, ”Dr Harsh Vardhan wrote in his tweet.

In another tweet, the union health minister said financial support was being provided to four manufacturers to expand production of Covaxin vaccines. These four companies are the new facility of Bharat Biotech in Bangalore, Haffkine Biopharmaceutical Corporation, Mumbai, Indian Immunologicals Ltd, Hyderabad and Bharat Immunologicals and Biologicals Ltd, Bulandshahr.

Earlier this week, the Indian government approved COVID-19 vaccines recognized by WHO and major countries around the world for emergency use in India. These foreign-made vaccines are the Russian vaccine Sputnik V, Moderna, Pfizer, and Johnson & Johnson.

ALSO READ  CBI registers FIR against ex-Trinamool MP KD Singh in money laundering case